- Home
- MNTK vs OCGN Comparison
MNTK vs OCGN Comparison
Compare MNTK & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- OCGN
- Stock Information
- Founded
- MNTK 1980
- OCGN 2013
- Country
- MNTK United States
- OCGN United States
- Employees
- MNTK N/A
- OCGN N/A
- Industry
- MNTK Natural Gas Distribution
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNTK Utilities
- OCGN Health Care
- Exchange
- MNTK Nasdaq
- OCGN Nasdaq
- Market Cap
- MNTK 306.2M
- OCGN 283.3M
- IPO Year
- MNTK 2021
- OCGN N/A
- Fundamental
- Price
- MNTK $2.32
- OCGN $1.09
- Analyst Decision
- MNTK Hold
- OCGN Strong Buy
- Analyst Count
- MNTK 3
- OCGN 3
- Target Price
- MNTK $3.33
- OCGN $6.00
- AVG Volume (30 Days)
- MNTK 213.0K
- OCGN 6.6M
- Earning Date
- MNTK 08-07-2025
- OCGN 08-01-2025
- Dividend Yield
- MNTK N/A
- OCGN N/A
- EPS Growth
- MNTK N/A
- OCGN N/A
- EPS
- MNTK 0.05
- OCGN N/A
- Revenue
- MNTK $179,552,000.00
- OCGN $4,522,000.00
- Revenue This Year
- MNTK $2.49
- OCGN N/A
- Revenue Next Year
- MNTK $26.02
- OCGN N/A
- P/E Ratio
- MNTK $44.54
- OCGN N/A
- Revenue Growth
- MNTK N/A
- OCGN N/A
- 52 Week Low
- MNTK $1.68
- OCGN $0.52
- 52 Week High
- MNTK $6.13
- OCGN $1.67
- Technical
- Relative Strength Index (RSI)
- MNTK 51.91
- OCGN 54.73
- Support Level
- MNTK $2.06
- OCGN $0.99
- Resistance Level
- MNTK $2.35
- OCGN $1.18
- Average True Range (ATR)
- MNTK 0.12
- OCGN 0.08
- MACD
- MNTK 0.01
- OCGN 0.00
- Stochastic Oscillator
- MNTK 59.09
- OCGN 54.55
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").